Literature DB >> 31066855

[Survival rate of 10 years among women with breast cancer: a historic cohort from 2000-2014].

Arlene Laurenti Monterrosa Ayala1, Juliana Cristine Dos Anjos2, Geraldo Antonio Cassol3, Doroteia Aparecida Höfelmann4.   

Abstract

Breast cancer is a public health problem due to its high incidence, morbidity and mortality. The analysis of survival for this disease contributes to the description of behavior and prognostic factors. The scope of this article is to investigate survival for 10 years after diagnosis and the prognostic factors of women with breast cancer admitted to the Unified Health System Mastology Service in Joinville, State of Santa Catarina, between 2000 and 2014. A historical cohort study with data from the medical records and death certificates of 1,321 women, of whom 471 were considered eligible under the minimum follow-up criteria of 10 years (n = 288), and/or death before this period (n = 183). Survival analysis using the Kaplan-Meier model, the Log-Rank test and the Cox regression model was conducted. Overall survival at 10 years was 41% (CI 95%, 36.1%-45.0%). The risk of 10-year mortality stratified by tumor staging was higher among women with lymphatic invasion and staging II, and staging III, at 60 years or older. The findings suggest that the presence of lymphatic invasion, advanced age and intermediate/advanced staging of the disease can be considered indicators of a worse prognosis for breast cancer.

Entities:  

Mesh:

Year:  2019        PMID: 31066855     DOI: 10.1590/1413-81232018244.16722017

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  1 in total

1.  Analysis of breast cancer survival in a northeastern Brazilian state based on prognostic factors: A retrospective cohort study.

Authors:  Adriane Dórea Marques; Alex Rodrigues Moura; Evânia Curvelo Hora; Érika de Abreu Costa Brito; Leonardo Souto Oliviera; Ionara Rodrigues Feitosa; Flavia Fernandes Freitas; Marcela Sampaio Lima; Íkaro Daniel de Carvalho Barreto; Marceli Oliveira Santos; Angela Maria da Silva; Carlos Anselmo Lima
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.